|

Lumason Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Infusion Administration, SonoVue

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • NaviFUS Corporation1
  • Bracco Diagnostics, Inc1

Indications

  • Heart Disease1
  • Neoplasms, Nerve Tissue1
  • Heart Diseases1
  • Neoplasms1
  • Glioblastoma Multiforme1

West Hills, California1 trial

Lumason® Infusion vs. Bolus Administrations

Interventional Cardiology Medical Group

Phase 3

Charlottesville, Virginia1 trial

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

University of Virginia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.